53727-29-0

Usage

Uses

Used in Pharmaceutical Industry:
1-METHYL-3-PHENYL-PYRIMIDINE-2,4,6-TRIONE is used as a therapeutic agent for the treatment of attention deficit hyperactivity disorder (ADHD) due to its ability to increase dopamine and norepinephrine levels in the brain, thereby improving focus, attention, and impulse control in affected individuals.
1-METHYL-3-PHENYL-PYRIMIDINE-2,4,6-TRIONE is also used as a medication for narcolepsy, a sleep disorder characterized by excessive daytime sleepiness and sudden episodes of muscle weakness, to help manage the symptoms and improve the quality of life for patients.

Upstream product

• 21236-97-5 3-methyl-6-aminouracil 
• 77-78-1 dimethyl sulfate 
• 42212-19-1 6-amino-3-methyl-1-phenylpyrimidine-2,4(1H,3H)dione 
• 1007-36-9 1-methyl-3-phenylurea 
• 72702-74-0 N-cyanoacetyl-N-methyl-N'-phenyl-urea 
• 141-82-2 malonic acid 

Downstream Products

• 53680-90-3 6-chloro-3-methyl-1-phenylpyrimidine-2,4(1H,3H)-dione 
• 176378-93-1 acetic acid 3-acetoxy-5-(3-methyl-6-methylamino-2,4-dioxo-1-phenyl-1,2,3,4-tetrahydro-pyrimidin-5-ylcarbamoyl)-phenyl ester 
• 176379-59-2 5-amino-3-methyl-6-methylamino-1-phenyluracil 
• 146723-69-5 3-methyl-6-methylamino-1-phenyluracil 
• 53681-13-3 6-hydrazino-3-methyl-1-phenyl-1H-pyrimidine-2,4-dione 
• 92978-75-1 5-(N,N-dimethylaminomethylene)-1-methyl-3-phenylbarbituric acid 
• 99851-82-8 5-bromo-1-methyl-3-phenyl-barbituric acid 

Relevant academic research and scientific papers

Synthesis and biological evaluation of CX-659S and its related compounds for their inhibitory effects on the delayed-type hypersensitivity reaction

In order to find novel nonsteroidal compounds possessing an inhibitory activity against delayed-type hypersensitivity (DTH) reactions, we conducted random screening using a picryl chloride (PC)-induced contact hypersensitivity reaction (CHR) in mice, and found compound 1 as a lead compound. Then we synthesized and evaluated an extensive series of 5-carboxamidouracil derivatives focused on both the uracil and the antioxidative moieties. Among them, we found that the hindered phenol moiety was necessary to exhibit the activities; especially, compounds 28a-28c having the partial structure of vitamin E were found to exert potent activities against the DTH reaction by both oral and topical administration. And compound 28c showed antioxidative activity against lipid peroxidation with an IC50 of 5.9μM. Compound 28c (CX-659S) was chosen as a candidate drug for the treatment of cutaneous disorders such as atopic dermatitis and allergic contact dermatitis. Copyright (C) 2000 Elsevier Science Ltd.

Cpecificy of Metylation by Dimethyl Sulfate of Barbituric Acid Salts and Alkyl Derivatives

Metylation of mono- and dianionic forms of barbituric acid, its C- and N-alkyl derivatives with dimethylsulfate is studied. The methylation of monoanions occurs at the C5 carbon or O4(6) oxygen atoms, while that of dianions presumably at N1(3) nitrogen atoms. The selectivity of the dianions metylation at the nitrogen atoms increases in going from potassium to sodium and even more to lithium salts.